FOSTIMON

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Finland, France, Ireland, Israel, Malta, Netherlands, Poland, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug FOSTIMON contains one active pharmaceutical ingredient (API):

1 Urofollitropin UNII W9BB98U6HP - UROFOLLITROPIN

Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure. Read about Urofollitropin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FOSTIMON Powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03GA04	Urofollitropin	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525213050018604, 525213050018704, 525213050018804, 525213050018904, 525213050019004, 525213050019104
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 22.453-1-01-06, 22.455-1-01-06
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 054768, 415813, 531676, 580901
Country: FR	Base de données publique des médicaments	Identifier(s): 60549797, 61166549, 62712912, 69325035
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 108913, 108921
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6065, 6066
Country: MT	Medicines Authority	Identifier(s): AA770/08601
Country: NL	Z-Index G-Standaard	Identifier(s): 15858693
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 104531, 116319, 121517, 82414
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100087044
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13533011, 13533012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680426040013, 8680426040020, 8680426040075, 8680426040082
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/21.10/0184